It is assumed that the immune pathogenesis of lung injury induced by mrmp is related to the amplification of host immune response (such as cytokine overproduction and T cell activation) Therefore, the use of immunomodulators such as corticosteroids or intravenous immunoglobulins (IVIgs) can reduce excessive host immune responses and improve clinical outcomes.<br>
正在翻译中..